Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (4) : Novartis

Yidu Tech Highlights AI’s Role in Accelerating Drug Development at Summer Davos 2026

Yidu Tech Highlights AI’s Role in Accelerating Drug Development at Summer Davos 2026
06/25/2026 | Companies
At the 17th Annual Meeting of the New Champions (Summer Davos 2026), organized by the World Economic Forum in Dalian on June 23, Gong Yingying, Founder and Chairwoman of Yidu Tech, joined a panel titled “Faster Drugs, Better Access?” to discuss the evolving landscape of pharmaceutical innovation....
AI agents in healthcare, AI in medicine, AI-powered healthcare, artificial intelligence in healthcare, biotechnology, BruHealth, Brunei healthcare, clinical research, clinical trial optimization, clinical trials, data sovereignty, data standardization, digital health, digital transformation in healthcare, disease knowledge graph, drug development, evidence-based medicine, global health innovation, global healthcare innovation, Gong Yingying, healthcare access, healthcare AI, healthcare analytics, healthcare compliance, healthcare data governance, healthcare data infrastructure, healthcare data management, healthcare digitization, healthcare ecosystem, healthcare infrastructure, healthcare innovation, healthcare policy, healthcare research, healthcare technology, healthcare transformation, life sciences, medical AI, medical research, medical technology, Novartis, patient recruitment, pharmaceutical innovation, pharmaceutical R&D, pharmaceutical technology, precision medicine, real-world evidence, Summer Davos, Summer Davos 2026, World Economic Forum, Yidu Tech, YiduCore

Novartis boosts value chain for stakeholders, embeds ESG in core business operations

Novartis boosts value chain for stakeholders, embeds ESG in core business operations
06/21/2022 | Companies
By embedding environmental, social and governance (ESG) topics into core business strategy and operations, Novartis aims to build trust with society and deliver long-term value to stakeholders. In February, the company released its first Novartis in Society Integrated Report 2021, marking a new...
core business operations, core business strategy, ESG, ESG professionals, GRI Standards Core Option, Integrated Reporting Framework, investors, long term value, Novartis, Novartis in Society Integrated Report 2021, SASB Standards, stakeholders, Task Force on Climate-related Financial Disclosures, TCFD

GSK And Novartis To Fund Research On African Genetic Diversity

GSK And Novartis To Fund Research On African Genetic Diversity
01/26/2021 | Economics
Together, both the companies have made a commitment of fund worth “2.8 million” over a period of five years. Dailycsr.com – 26 January 2021 – On January 19, 2021, Novartis and GSK made an announcement about their collaboration on supporting “high-quality scientific research” that investigates the...
Africa, Funding, Genetic Diversity, Genomic Research Approach for Diversity and Optimizing Therapeutics, GRADIENT, GSK, malaria, Novartis, Project Africa, Research, treatment, tuberculosis

Sounding The Contextual Depths Of Novartis’ CR Performance Of 2016

Sounding The Contextual Depths Of Novartis’ CR Performance Of 2016
02/01/2017 | Companies
Novartis’ 2016 CR report supports its improved ranking standing for its performance. Dailycsr.com – 01 February 2017 – The report for Novartis’ Corporate Responsibility Performance for the year of 2016 has been published now, whereby the new report covers a deeper contextual details in regards to...
CR Performance, Healthcare, Leader, Novartis, Rank, Recognition, Report 2016


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com